Goal-Directed Fluid Therapy (GDFT)

Definition & Historical Background

"GDFT aims to avoid both hypovolemia and fluid excess, and it is the optimal approach for fluid administration in high-risk surgical patients."

• Morgan and Mikhail's Clinical Anesthesiology, 7e

The Core Problem GDFT Addresses

Physiological Basis

Frank-Starling Mechanism

A high PPV (~25%) indicates the patient is on the steep part of the Frank-Starling curve and is fluid responsive. After volume loading, PPV falls (~7%), indicating the patient has reached the plateau. (Morgan and Mikhail's Clinical Anesthesiology, 7e)

Respirophasic Hemodynamic Variation

1. Increases intrathoracic pressure
2. Reduces venous return to the right ventricle
3. Decreases RV stroke volume
4. This propagates to reduce LV stroke volume ~2-3 beats later (during expiration)

Hemodynamic Targets in GDFT

Static vs. Dynamic Parameters

Pulse Pressure Variation (PPV)

PPV = [(PP_max - PP_min) / PP_mean] × 100

• PPV >12-13% = fluid responsive (predicts >15% increase in CO with a 500 mL crystalloid bolus)
• PPV <10% = euvolemic; further fluid unlikely to benefit
• Administer fluid boluses until PPV falls below 10%

• Valid ONLY in mechanically ventilated patients with tidal volume ≥8 mL/kg
• Requires sinus rhythm (atrial fibrillation/ectopy invalidates the metric)
• Patients must be synchronous with the ventilator (not actively breathing)
• Unreliable with open chest (not with open abdomen)
• Less studied at modern low tidal volumes (6 mL/kg)

Monitoring Devices

Fluid Choice in GDFT

GDFT Algorithm (Typical Perioperative Protocol)

Start with baseline crystalloid 3-5 mL/kg/h
          ↓
Measure PPV or SVV continuously
          ↓
PPV >12-13%? → Give colloid bolus 250-500 mL
          ↓
Reassess PPV after bolus
          ↓
PPV still >12% → repeat bolus
PPV <10%      → maintain; no further bolus
          ↓
If MAP <65 despite adequate preload → add vasopressor (norepinephrine)
If low CO despite euvolemia → consider inotrope (dobutamine)

GDFT in Context: When is it Beneficial?

"Goal-directed fluid therapy is a good example of an intervention that is effective in the perioperative phase, but ineffective in established critical illness."

• Miller's Anesthesia, 10e

Blood Loss Management Within GDFT

• Replace blood loss with crystalloid at 3-4:1 ratio OR colloid at 1:1 until transfusion trigger reached
• Transfusion trigger: Hb <7 g/dL in healthy patients; higher threshold (Hb 8-9 g/dL) for elderly, cardiac/pulmonary disease, reduced mixed venous O₂ saturation + tachycardia
• Allowable blood loss = (RBCVpreop - RBCV₃₀%) × 3

Key Takeaways

1. GDFT individualizes fluid administration using hemodynamic endpoints, avoiding the harms of both under- and over-resuscitation.
2. PPV and SVV are the best-validated dynamic predictors of fluid responsiveness, but only in fully mechanically ventilated, arrhythmia-free patients.
3. Fluid boluses (typically 250-500 mL colloid) are given when PPV >12-13% and stopped when PPV falls below 10%.
4. In low-risk and laparoscopic ERAS patients, a simple "zero-balance" strategy with 3-5 mL/kg/h balanced crystalloid is sufficient.
5. MAP <65 mmHg despite optimized preload should prompt vasopressors, not more fluid.
6. GDT is effective perioperatively but has not shown benefit in established critical illness.

• Morgan and Mikhail's Clinical Anesthesiology, 7e
• Miller's Anesthesia, 10e
• Barash et al., Clinical Anesthesia, 9e
• Current Surgical Therapy, 14e
• Tintinalli's Emergency Medicine

• Jin et al. 2025, Anesth Analg - GDFT in oncologic surgery (PMID 40305698)
• Lasanudin & Mauna 2024 - GDFT in elderly (PMID 40994091)
• Li et al. 2023 - GDFT in thoracic surgery (PMID 37723513)
• Felippe et al. 2025 - Non-invasive GDFT with PVI (PMID 40778974)

Goal-Directed Fluid Therapy - Advanced Topics

1. Fluid Responsiveness: The Core Concept

2. Dynamic Tests of Fluid Responsiveness

A. Passive Leg Raise (PLR) - The Universal Test

• Start semi-recumbent (45°)
• Lower head to horizontal, raise legs to 45° simultaneously
• Measure CO or SV change within 60-90 seconds (the effect is transient)
• Positive: ≥10% increase in CO/SV = fluid responsive

• Works in spontaneously breathing patients (PPV/SVV cannot)
• Works in arrhythmia
• Works in low tidal volume ventilation
• Completely reversible - if the patient deteriorates, lowering the legs returns the fluid

B. Fluid Challenge (Mini-Challenge)

• Positive response: ≥10% increase in SV or CO
• Sensitivity and specificity are comparable to larger challenges when CO is measured continuously
• Closed-loop GDFT systems by Cannesson et al. use 100 mL mini-challenges to maximize SV index while minimizing total fluid given

C. End-Expiratory Occlusion (EEO) Test

• Maneuver: Pause the ventilator at end-expiration for 15 seconds
• This temporarily interrupts the cyclic decrease in venous return caused by PPV
• Acts as a sustained preload increase
• Positive: ≥5% increase in pulse pressure or CO = fluid responsive

D. Tidal Volume Challenge

• Transiently increase tidal volume from 6 to 8 mL/kg for one minute
• Measure change in PPV or SVV
• A significant increase in PPV/SVV predicts fluid responsiveness

3. Echocardiographic Indices of Fluid Responsiveness

VExUS Score (Venous Congestion Assessment)

• IVC diameter >2 cm + abnormal hepatic vein / portal vein Doppler patterns
• Graded 0-3; higher scores predict AKI risk
• Helps decide when to stop fluids or initiate de-resuscitation

4. GDFT in Sepsis

Initial Resuscitation Phase (0-3 hours)

• 30 mL/kg balanced crystalloid within the first 3 hours (Surviving Sepsis)
• MAP target: >65 mmHg (vasopressors if not met with volume)
• Dynamic tests (PLR, fluid challenge) recommended over static CVP targets
• Albumin may supplement crystalloids if large volumes required; other colloids not recommended

Established Sepsis / Later Phase

• Fluid responsiveness becomes decoupled from oxygen delivery due to cytopathic hypoxia (cellular inability to utilize O₂)
• Elevating global DO₂ may give no benefit while increasing harm
• A less-positive fluid balance is associated with improved outcomes
• ARDS + sepsis: conservative fluid strategy reduces ventilator days

"In established sepsis, there is uncoupling of the O₂ delivery and consumption relationship as a result of cellular inability to use O₂ (cytopathic hypoxia). Because of this, strategies to elevate global O₂ delivery may be of little benefit while exposing patients to potential side effects of excessive fluid."

• Miller's Anesthesia, 10e

5. Fluid Type Selection

The Crystalloid Debate: Balanced vs. Normal Saline

Colloids in GDFT

6. Closed-Loop GDFT: The Next Frontier

• Developed primarily by Cannesson et al. (University of California)
• The system monitors PPV/SVV continuously, administers 100 mL mini-fluid challenges when SVV exceeds a threshold, and simultaneously titrates vasopressors (norepinephrine) to keep MAP within ±10% of baseline
• In case-control studies, closed-loop GDFT during major abdominal surgery:
  • Reduced intraoperative net fluid balance
  • Reduced postoperative complications
  • Shortened hospital length of stay
• Closed-loop vasopressor systems maintained MAP within ±5 mmHg of target for 91.6% of the intraoperative period vs. lower precision with manual control
• Currently used within research settings only; FDA is formulating regulatory proposals

7. GDFT Across Clinical Contexts

8. Limitations and Controversies

1. The RELIEF Trial Problem

2. PPV/SVV Validity Concerns

• Only validated at Vt ≥8 mL/kg; modern lung-protective ventilation uses 6 mL/kg
• Requires passive mechanical ventilation (no spontaneous breathing)
• Requires sinus rhythm
• Intra-abdominal hypertension, right heart failure, and open chest all impair accuracy

3. GDT in ERAS - Diminishing Returns

4. Monitoring Device Agreement

5. GDT is Perioperative, Not ICU-Wide

9. Summary Framework: Choosing Your GDFT Approach

Patient undergoing surgery
         │
         ├─► Low risk / laparoscopic / ERAS
         │       → 3-5 mL/kg/h balanced crystalloid
         │       → No advanced monitoring needed
         │       → Aim zero fluid balance
         │
         └─► High risk / major open surgery / expected blood loss >1L
                 │
                 ├─► Mechanically ventilated, sinus rhythm, Vt ≥8 mL/kg?
                 │       → Use PPV/SVV (pulse contour device)
                 │       → Bolus if PPV >12%, stop if PPV <10%
                 │
                 ├─► Spontaneous breathing / arrhythmia / low Vt?
                 │       → PLR + real-time CO measure (echo, Doppler)
                 │       → Or EEO test
                 │
                 └─► All settings
                         → MAP ≥65 mmHg (vasopressor if not met by volume)
                         → Replace blood loss: crystalloid 1:3 or colloid 1:1
                         → Transfuse if Hb <7 (or <8-9 in high-risk cardiac pts)
                         → Balanced crystalloid always (not 0.9% NaCl in large volumes)

• Miller's Anesthesia, 10e (Fluid Responsiveness, Sepsis, Closed-Loop, Perioperative Fluid)
• Morgan and Mikhail's Clinical Anesthesiology, 7e (GDFT, PPV, Fluid Tables)
• Barash et al., Clinical Anesthesia, 9e (Dynamic Respiratory Indices)
• Current Surgical Therapy, 14e (ERAS, Hemodynamic Management)
• Tintinalli's Emergency Medicine (PPV in mechanical ventilation)